ReviewBMC medicine2026
Outcome measurement for multiple long-term conditions research across health-care settings - an overview of reviews.
Review in BMC medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
Abstract
backgroundMultiple long-term conditions (MLTC) represent a growing global public health challenge, yet research is hindered by inconsistent outcomes across health-care settings and populations. Although several core outcome sets (COS) have been developed, important gaps remain in their coverage, inclusivity, and measurement validity. This overview of reviews summarised outcomes reported in systematic reviews of MLTC research to identify existing domains, describe how measurement instruments were addressed, and highlight areas requiring standardisation.
methodsWe conducted a prospectively registered overview of reviews (PROSPERO CRD420251005152), following PRISMA, PRIOR, and SWiM guidelines. Eligible reviews included adults or children with MLTC-defined as the coexistence of two or more chronic conditions-and reported on outcome measures or COS relevant to this population. Five databases (MEDLINE, CINAHL, Scopus, Cochrane Library, COMET (Core Outcome Measures in Effectiveness Trials)) were searched from inception to April 2025. Two reviewers independently screened, extracted data, and appraised quality using the Joanna Briggs Institute checklist. A narrative synthesis mapped outcomes by domain (clinical, patient-reported, service/system, engagement/experience), care setting, and population subgroup.
resultsFrom 6331 records, 10 reviews met inclusion criteria, encompassing 709 primary studies. Four developed COS, and six mapped outcomes without proposing COS. Quality of life and health-care utilisation were most consistently reported; treatment burden, patient engagement, and child outcomes were infrequently assessed. Existing COS advanced standardisation but remained limited in stakeholder diversity, geographic scope, and specification of measurement instruments, with only one including low- and middle-income countries.
conclusionsGreater inclusivity, validation, and global applicability are needed to operationalise agreed domains and improve comparability across MLTC research.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.